NCT07042581 - A Study of Revaree Plus in People With Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

June 20, 2029

Study Completion Date

June 20, 2029

Conditions

Breast CancerStage 0 Breast CancerStage I Breast CancerStage II Breast CancerStage III Breast CancerStage 0 Breast CarcinomaStage II Breast CarcinomaStage III Breast CarcinomaHormone-receptor-positive Breast CancerHormone Receptor Positive Breast CarcinomaHormone Receptor Positive Malignant Neoplasm of Breast

Interventions

DRUG

Revaree Plus

Revaree Plus is a hyaluronic acid vaginal suppository

Trial Locations (7)

10021

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (Consent Only), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Consent Only), Uniondale

11725

RECRUITING

Memorial Sloan Kettering Cancer Center Suffolk-Commack (Consent Only), Commack

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Consent Only), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Consent Only), Montvale

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER